MTFR2

gene
On this page

Summary

MTFR2 (mitochondrial fission regulator 2, HGNC:21115) is a protein-coding gene on chromosome 6q23.3, encoding Mitochondrial fission regulator 2 (Q6P444). May play a role in mitochondrial aerobic respiration essentially in the testis.

Predicted to be involved in aerobic respiration and mitochondrial fission. Located in mitochondrion.

Source: NCBI Gene 113115 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 72 total
  • MANE Select transcript: NM_001099286

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21115
Approved symbolMTFR2
Namemitochondrial fission regulator 2
Location6q23.3
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000146410
Ensembl biotypeprotein_coding
Entrez113115

Gene structure

Transcript identifiers

Ensembl transcripts: 9 — 6 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000367784, ENST00000418509, ENST00000420702, ENST00000445767, ENST00000451457, ENST00000527338, ENST00000532958, ENST00000919551, ENST00000952723

RefSeq mRNA: 3 — MANE Select: NM_001099286 NM_001099286, NM_001318738, NM_138419

CCDS: CCDS5176

Canonical transcript exons

ENST00000420702 — 8 exons

ExonStartEnd
ENSE00001629537136249976136250311
ENSE00003515364136241444136241676
ENSE00003559383136231034136231388
ENSE00003565761136244765136244869
ENSE00003573198136233325136233499
ENSE00003592532136249037136249153
ENSE00003636140136242861136242973
ENSE00003642674136239466136239820

Expression profiles

Bgee: expression breadth ubiquitous, 190 present calls, max score 94.87.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.9445 / max 88.6392, expressed in 968 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
757422.9445968

Top tissues by expression

254 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
buccal mucosa cellCL:000233694.87gold quality
secondary oocyteCL:000065592.50gold quality
oocyteCL:000002391.61gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099187.44gold quality
spermCL:000001986.58gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.04gold quality
ventricular zoneUBERON:000305379.22gold quality
ileal mucosaUBERON:000033177.24gold quality
right testisUBERON:000453476.16gold quality
testisUBERON:000047376.00gold quality
bone marrowUBERON:000237175.96gold quality
left testisUBERON:000453375.48gold quality
mucosa of transverse colonUBERON:000499175.11gold quality
rectumUBERON:000105273.43gold quality
trabecular bone tissueUBERON:000248373.21gold quality
ganglionic eminenceUBERON:000402373.12gold quality
vermiform appendixUBERON:000115472.81gold quality
stromal cell of endometriumCL:000225571.62gold quality
tibialis anteriorUBERON:000138570.46gold quality
lymph nodeUBERON:000002970.18gold quality
gingival epitheliumUBERON:000194970.18gold quality
esophagus mucosaUBERON:000246968.96gold quality
epithelium of nasopharynxUBERON:000195168.93gold quality
lower esophagus mucosaUBERON:003583468.19gold quality
amniotic fluidUBERON:000017367.89gold quality
thymusUBERON:000237067.66gold quality
granulocyteCL:000009467.37gold quality
palpebral conjunctivaUBERON:000181267.10gold quality
pancreatic ductal cellCL:000207966.95silver quality
adult organismUBERON:000702366.81gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes4.49

Regulation

Is transcription factor: yes

Downstream targets (CollecTRI)

1 targets.

TargetRegulation
TP53Unknown

miRNA regulators (miRDB)

22 targeting MTFR2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-318599.9968.121959
HSA-MIR-449699.8868.892236
HSA-LET-7A-2-3P99.8770.531921
HSA-LET-7G-3P99.8570.431929
HSA-MIR-132-3P99.7370.561424
HSA-MIR-212-3P99.7370.651424
HSA-MIR-33A-3P99.7070.273362
HSA-MIR-426199.5970.303415
HSA-MIR-6513-3P99.5969.771102
HSA-MIR-147B-5P99.4570.622432
HSA-MIR-4797-5P99.3968.011354
HSA-MIR-6507-5P99.3670.462524
HSA-MIR-426399.1869.252236
HSA-MIR-455-3P98.9467.68878
HSA-MIR-6796-3P98.6865.49689
HSA-MIR-477398.3567.301710
HSA-MIR-1212098.0568.441768
HSA-MIR-92497.7866.21681
HSA-MIR-376C-3P97.6368.881263
HSA-MIR-59296.5967.59817
HSA-MIR-6806-5P96.3768.74587
HSA-MIR-217-3P95.6768.421000

Literature-anchored findings (GeneRIF, showing 6)

  • Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cells. (PMID:31740625)
  • Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformatics. (PMID:34039308)
  • Upregulated expression of MTFR2 as a novel biomarker predicts poor prognosis in hepatocellular carcinoma by bioinformatics analysis. (PMID:34156259)
  • Transcription factor HOXC10 activates the expression of MTFR2 to regulate the proliferation, invasion and migration of colorectal cancer cells. (PMID:34523692)
  • Dysregulation of MTFR2, ATP5IF1 and BAK1 in Sertoli cells relates to idiopathic non-obstructive azoospermia via inhibiting mitochondrial fission and inducing mitochondrial dysfunctiondagger. (PMID:37903059)
  • MTFR2-dependent mitochondrial fission promotes HCC progression. (PMID:38238834)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriomtfr2ENSDARG00000060394
mus_musculusMtfr2ENSMUSG00000019992
rattus_norvegicusENSRNOG00000078862

Paralogs (2): MTFR1 (ENSG00000066855), MTFR1L (ENSG00000117640)

Protein

Protein identifiers

Mitochondrial fission regulator 2Q6P444 (reviewed: Q6P444)

Alternative names: DUF729 domain-containing protein 1

All UniProt accessions (3): Q6P444, E9PN39, H0YEA6

UniProt curated annotations — full annotation on UniProt →

Function. May play a role in mitochondrial aerobic respiration essentially in the testis. Can also promote mitochondrial fission.

Subcellular location. Mitochondrion.

Miscellaneous. May be produced at very low levels due to a premature stop codon in the mRNA, leading to nonsense-mediated mRNA decay.

Similarity. Belongs to the MTFR1 family.

Isoforms (2)

UniProt IDNamesCanonical?
Q6P444-11yes
Q6P444-22

RefSeq proteins (3): NP_001092756, NP_001305667, NP_612428 (=MANE)

Domains & families (InterPro)

IDNameType
IPR007972Mtfr1Family

Pfam: PF05308

UniProt features (13 total): modified residue 4, compositionally biased region 3, splice variant 2, region of interest 2, initiator methionine 1, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q6P444-F162.110.11

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (4): 328, 2, 119, 291

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 158 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_ORGANELLE_FISSION, MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN, FOSTER_TOLERANT_MACROPHAGE_UP, GOBP_MITOCHONDRIAL_FISSION, DODD_NASOPHARYNGEAL_CARCINOMA_UP, FISCHER_DREAM_TARGETS, TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP, GOBP_CELLULAR_RESPIRATION, NUYTTEN_EZH2_TARGETS_DN, MARSON_BOUND_BY_E2F4_UNSTIMULATED

GO Biological Process (3): mitochondrial fission (GO:0000266), mitochondrion organization (GO:0007005), aerobic respiration (GO:0009060)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (1): mitochondrion (GO:0005739)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
mitochondrion organization1
organelle fission1
organelle organization1
cellular respiration1
binding1
cytoplasm1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

1166 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MTFR2DERL1Q9BUN8431
MTFR2KRTAP19-7Q3SYF9431
MTFR2C4orf46Q504U0374
MTFR2OR6X1Q8NH79370
MTFR2OR13J1Q8NGT2366
MTFR2ZNF565Q8N9K5359
MTFR2SHCBP1Q8NEM2348
MTFR2TTKP33981338
MTFR2FAM181AQ8N9Y4305
MTFR2CENPNQ96H22304
MTFR2ZNF781Q8N8C0303
MTFR2POTEMA6NI47303
MTFR2FAM72BQ86X60274
MTFR2TTC14Q96N46271
MTFR2ZNF791Q3KP31269
MTFR2PHETA1Q8N4B1269

IntAct

53 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
ALAS1MTFR2psi-mi:“MI:0915”(physical association)0.560
MTFR2ALAS1psi-mi:“MI:0915”(physical association)0.560
MTFR2TRIM23psi-mi:“MI:0915”(physical association)0.560
GOLGA2MTFR2psi-mi:“MI:0915”(physical association)0.560
MAGEA12MTFR2psi-mi:“MI:0915”(physical association)0.560
TFIP11MTFR2psi-mi:“MI:0915”(physical association)0.560
TRIM23MTFR2psi-mi:“MI:0915”(physical association)0.560
MTFR2GOLGA2psi-mi:“MI:0915”(physical association)0.560
MTFR2TFIP11psi-mi:“MI:0915”(physical association)0.560
MTFR2MAGEA12psi-mi:“MI:0915”(physical association)0.560
SLC2A12METTL15psi-mi:“MI:0914”(association)0.530
NPY2RRTL8Cpsi-mi:“MI:0914”(association)0.530
SCNN1DABHD16Apsi-mi:“MI:0914”(association)0.530
ATG14CETN2psi-mi:“MI:0914”(association)0.530
MTFR2CFTRpsi-mi:“MI:0915”(physical association)0.520
HTRA2HAX1psi-mi:“MI:2364”(proximity)0.420
MTFR2SIRT1psi-mi:“MI:0915”(physical association)0.400
MTFR2KLHDC2psi-mi:“MI:0915”(physical association)0.400
MTFR2SPTBpsi-mi:“MI:0915”(physical association)0.400
PB2ESYT2psi-mi:“MI:0914”(association)0.350

BioGRID (66): MTFR2 (Two-hybrid), MTFR2 (Two-hybrid), MTFR2 (Two-hybrid), MTFR2 (Two-hybrid), MTFR2 (Two-hybrid), KLHDC2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), SIRT1 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS), MTFR2 (Affinity Capture-MS)

ESM2 similar proteins: A2AIW0, A2YX04, A5WUN7, A8MWX3, B0K035, B2GUZ2, D3IUT5, D4A4D7, F1RCE7, G3V9A7, Q08BD8, Q0VFP3, Q3ZBW7, Q4R707, Q4V7T5, Q52KF3, Q58CR1, Q5R3Z9, Q5T5Y3, Q5XII9, Q640U0, Q641E3, Q6AWX6, Q6DF94, Q6GP48, Q6IRN6, Q6NPP4, Q6P444, Q6S7F2, Q6Z8M8, Q700C2, Q75LH6, Q7T3E8, Q7YR76, Q8BHE0, Q8C263, Q8GSA7, Q8IZQ8, Q8K298, Q8RY95

Diamond homologs: B0K035, F1RCE7, G3V9A7, Q08BD8, Q0VFP3, Q3ZBW7, Q4V7T5, Q58CR1, Q5R3Z9, Q5RFN3, Q5XII9, Q6GP48, Q6P444, Q7T3E8, Q8VED8, Q99MB2, Q9CWE0, Q9H019, Q15390, Q9PTD5

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

72 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance57
Likely benign5
Benign1

Top pathogenic / likely-pathogenic (0)

SpliceAI

1050 predictions. Top by Δscore:

VariantEffectΔscore
6:136231384:CCAAA:Cacceptor_gain1.0000
6:136231385:CAAA:Cacceptor_gain1.0000
6:136231385:CAAAC:Cacceptor_gain1.0000
6:136231388:ACTG:Aacceptor_loss1.0000
6:136231389:C:CCacceptor_gain1.0000
6:136233319:GCTTA:Gdonor_loss1.0000
6:136233320:CTTA:Cdonor_loss1.0000
6:136233322:T:TGdonor_loss1.0000
6:136233323:A:ACdonor_gain1.0000
6:136233323:AC:Adonor_gain1.0000
6:136233324:C:CCdonor_gain1.0000
6:136233324:C:CTdonor_loss1.0000
6:136233324:CC:Cdonor_gain1.0000
6:136241440:TTA:Tdonor_loss1.0000
6:136241441:TAC:Tdonor_loss1.0000
6:136241442:A:ACdonor_gain1.0000
6:136241442:ACTAG:Adonor_loss1.0000
6:136241443:C:Adonor_loss1.0000
6:136241443:C:CAdonor_gain1.0000
6:136241443:CT:Cdonor_gain1.0000
6:136241443:CTA:Cdonor_gain1.0000
6:136241443:CTAG:Cdonor_gain1.0000
6:136241443:CTAGA:Cdonor_gain1.0000
6:136241467:T:Adonor_gain1.0000
6:136241672:TATTT:Tacceptor_gain1.0000
6:136241673:ATTT:Aacceptor_gain1.0000
6:136241674:TTT:Tacceptor_gain1.0000
6:136241675:TT:Tacceptor_gain1.0000
6:136241677:C:CCacceptor_gain1.0000
6:136241678:T:Cacceptor_loss1.0000

AlphaMissense

2537 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
6:136244825:A:CS36R0.988
6:136244825:A:TS36R0.988
6:136244827:T:GS36R0.988
6:136241512:A:GL149P0.987
6:136244820:A:TV38D0.980
6:136241503:A:GL152P0.976
6:136233406:A:CF321L0.975
6:136233406:A:TF321L0.975
6:136233408:A:GF321L0.975
6:136233419:A:TL317H0.975
6:136244817:C:GR39P0.975
6:136233340:A:CS343R0.970
6:136233340:A:TS343R0.970
6:136233342:T:GS343R0.970
6:136233419:A:GL317P0.970
6:136244818:G:TR39S0.969
6:136233423:C:GA316P0.967
6:136241489:C:GA157P0.966
6:136239505:A:GL277P0.964
6:136241494:T:GQ155P0.963
6:136241524:A:GL145P0.958
6:136233431:A:TI313K0.957
6:136241500:C:GR153P0.952
6:136244777:T:AR52S0.950
6:136244777:T:GR52S0.950
6:136244808:C:TG42E0.946
6:136244826:C:AS36I0.943
6:136233431:A:GI313T0.942
6:136244828:C:AR35S0.942
6:136244828:C:GR35S0.942

dbSNP variants (sampled 300 via entrez): RS1000303532 (6:136236006 C>T), RS1000494300 (6:136247485 T>C), RS1000895421 (6:136251735 A>G), RS1001083912 (6:136248045 C>G), RS1001110114 (6:136246069 C>A,T), RS1001536579 (6:136247564 T>C), RS1001545979 (6:136243197 C>A,T), RS1001581877 (6:136246924 A>G), RS1001632248 (6:136240918 CG>C), RS1001717004 (6:136232403 T>C), RS1001819076 (6:136235642 A>C), RS1001834395 (6:136249351 T>C), RS1001884750 (6:136244542 C>T), RS1002057356 (6:136233769 T>C), RS1002469940 (6:136245258 T>A,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST009391_790Metabolite levels2.000000e-06

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010395sphingomyelin 22:0 measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

57 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Cyclosporinedecreases expression3
sodium arseniteincreases expression, decreases expression2
(+)-JQ1 compounddecreases expression, increases expression2
Valproic Aciddecreases methylation, increases expression2
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression2
aristolochic acid Idecreases expression1
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
afuresertibdecreases expression1
FR900359decreases phosphorylation1
TAK-243increases sumoylation1
dicrotophosdecreases expression1
bisphenol Adecreases expression1
arseniteaffects binding, increases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
zinc chromatedecreases expression, increases abundance1
isobutyl alcoholaffects cotreatment, decreases expression, increases abundance1
chromium hexavalent iondecreases expression, increases abundance1
CGP 52608affects binding, increases reaction1
perfluoro-n-nonanoic aciddecreases expression1
K 7174decreases expression1
teriflunomidedecreases expression1
jinfukangincreases expression1
incobotulinumtoxinAdecreases expression1
theaflavin-3,3’-digallateaffects expression1
Dasatinibdecreases expression1
Resveratrolaffects cotreatment, increases expression1
Temozolomideincreases expression1
Vorinostatincreases expression1
Acetaminophenincreases expression1
Air Pollutantsaffects expression, increases abundance1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.